The Enterprise Value as of December 2024 (TTM) for Portage Biotech Inc. (PRTG) is 4.08M

According to Portage Biotech Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 4.08M. This represents a change of -98.38% compared to the average of 251.23M of the last 4 quarters.

Portage Biotech Inc. (PRTG) Historical Enterprise Value (quarterly & annually)

How has PRTG Enterprise Value performed in the past?

The mean historical Enterprise Value of Portage Biotech Inc. over the last ten years is 1.48B. The current 4.08M Enterprise Value has changed -72.37% with respect to the historical average. Over the past ten years (40 quarters), PRTG's Enterprise Value was at its highest in in the March 2021 quarter at 6.73B. The Enterprise Value was at its lowest in in the June 2024 quarter at 811.16K.

Portage Biotech Inc. (PRTG) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Portage Biotech Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Portage Biotech Inc. (PRTG) Average Enterprise Value

How has PRTG Enterprise Value performed in the past?

The current Enterprise Value of Portage Biotech Inc. (PRTG) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Portage Biotech Inc. (PRTG) Enterprise Value vs. Peers

How is PRTG’s Enterprise Value compared to its peers?

Portage Biotech Inc.’s Enterprise Value is less than Amylyx Pharmaceuticals, Inc. (204.92M), less than Karuna Therapeutics, Inc. (12.43B), less than Blueprint Medicines Corporation (6.13B), less than Arvinas, Inc. (1.20B), less than Aerovate Therapeutics, Inc. (44.50M), less than Eliem Therapeutics, Inc. (0), less than Anebulo Pharmaceuticals, Inc. (40.61M), less than Cue Biopharma, Inc. (41.08M), less than Decibel Therapeutics, Inc. (102.82M), less than Keros Therapeutics, Inc. (165.48M), less than Janux Therapeutics, Inc. (3.24B), less than Fennec Pharmaceuticals Inc. (161.56M), less than Edgewise Therapeutics, Inc. (2.76B), less than Harmony Biosciences Holdings, Inc. (1.74B), less than Lineage Cell Therapeutics, Inc. (93.41M), less than MAIA Biotechnology, Inc. (41.72M), less than Armata Pharmaceuticals, Inc. (197.00M), less than Frequency Therapeutics, Inc. (384.22M), less than Day One Biopharmaceuticals, Inc. (857.57M), less than Acumen Pharmaceuticals, Inc. (104.35M), less than X4 Pharmaceuticals, Inc. (79.71M), less than Inozyme Pharma, Inc. (210.44M), less than VectivBio Holding AG (848.58M),

Build a custom stock screener for Portage Biotech Inc. (PRTG) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Portage Biotech Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Portage Biotech Inc. (PRTG) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Portage Biotech Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.